華邦健康(002004.SZ):穎泰生物擬公開發行股票並在股轉系統精選層掛牌
格隆匯2月13日丨華邦健康(002004.SZ)公佈,公司控股子公司北京穎泰嘉和生物科技股份有限公司(“穎泰生物”)系全國中小企業股份轉讓系統(“股轉系統”或“新三板”)掛牌公司,證券簡稱為:穎泰生物,證券代碼為:833819。
穎泰生物於2020年2月13日召開第二屆董事會第十次會議,審議通過了《關於申請向不特定合格投資者公開發行股票並在精選層掛牌的方案》等議案,穎泰生物擬向不特定合格投資者公開發行股票,具體發行數量、發行價格將依據相關法律法規並綜合考慮市場情況另行確定。扣除發行費用之後,穎泰生物所募集的資金將按照國家法律法規和監管機構的規定及其自身業務發展的需要,用於項目建設、補充流動資金或償還銀行貸款等用途。本次公開發行股票完成並經監管機構審核後,穎泰生物將在股轉系統精選層完成掛牌。
公司控股子公司穎泰生物公開發行股票並在股轉系統精選層掛牌,有助於穎泰生物藉助新三板深化改革的發展機遇,以及精選層在資本市場中承上啟下的作用,拓寬融資渠道,為其在資本市場發展開拓更好的前進道路。同時,該事項的推進也將提升公司持有的穎泰生物股份的價值,實現公司全體股東利益的最大化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.